Connor, Clark & Lunn Investment Management (CC&L)’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.09M | Buy |
900,256
+68,567
| +8% | +$235K | 0.01% | 725 |
|
2025
Q1 | $2.46M | Buy |
831,689
+344,321
| +71% | +$1.02M | 0.01% | 676 |
|
2024
Q4 | $1.49M | Buy |
487,368
+118,913
| +32% | +$363K | 0.01% | 809 |
|
2024
Q3 | $940K | Buy |
368,455
+13,941
| +4% | +$35.6K | ﹤0.01% | 903 |
|
2024
Q2 | $1.16M | Sell |
354,514
-31,349
| -8% | -$102K | ﹤0.01% | 815 |
|
2024
Q1 | $2.05M | Buy |
385,863
+189,204
| +96% | +$1M | 0.01% | 666 |
|
2023
Q4 | $852K | Sell |
196,659
-3,108
| -2% | -$13.5K | ﹤0.01% | 904 |
|
2023
Q3 | $525K | Hold |
199,767
| – | – | ﹤0.01% | 1001 |
|
2023
Q2 | $705K | Buy |
199,767
+15,822
| +9% | +$55.9K | ﹤0.01% | 893 |
|
2023
Q1 | $568K | Buy |
183,945
+675
| +0.4% | +$2.09K | ﹤0.01% | 848 |
|
2022
Q4 | $775K | Buy |
183,270
+33,976
| +23% | +$144K | ﹤0.01% | 770 |
|
2022
Q3 | $354K | Buy |
149,294
+71,703
| +92% | +$170K | ﹤0.01% | 882 |
|
2022
Q2 | $221K | Sell |
77,591
-13,140
| -14% | -$37.4K | ﹤0.01% | 912 |
|
2022
Q1 | $261K | Sell |
90,731
-9,484
| -9% | -$27.3K | ﹤0.01% | 901 |
|
2021
Q4 | $305K | Buy |
+100,215
| New | +$305K | ﹤0.01% | 892 |
|
2020
Q2 | – | Sell |
-11,467
| Closed | -$97K | – | 1143 |
|
2020
Q1 | $97K | Buy |
+11,467
| New | +$97K | ﹤0.01% | 936 |
|
2016
Q4 | – | Sell |
-3,925
| Closed | -$263K | – | 960 |
|
2016
Q3 | $263K | Sell |
3,925
-22,800
| -85% | -$1.53M | ﹤0.01% | 696 |
|
2016
Q2 | $796K | Sell |
26,725
-525
| -2% | -$15.6K | 0.01% | 505 |
|
2016
Q1 | $800K | Sell |
27,250
-2,100
| -7% | -$61.7K | 0.01% | 494 |
|
2015
Q4 | $2.3M | Sell |
29,350
-6,525
| -18% | -$512K | 0.02% | 309 |
|
2015
Q3 | $2.7M | Buy |
35,875
+275
| +0.8% | +$20.7K | 0.02% | 262 |
|
2015
Q2 | $4.16M | Buy |
35,600
+600
| +2% | +$70K | 0.04% | 169 |
|
2015
Q1 | $8.26M | Buy |
35,000
+14,100
| +67% | +$3.33M | 0.07% | 129 |
|
2014
Q4 | $3.96M | Buy |
20,900
+12,300
| +143% | +$2.33M | 0.03% | 175 |
|
2014
Q3 | $2.05M | Buy |
+8,600
| New | +$2.05M | 0.02% | 214 |
|